---
document_datetime: 2023-09-21 18:21:10
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nevanac-epar-all-authorised-presentations_en.pdf
document_name: nevanac-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9396722
conversion_datetime: 2025-12-26 17:04:13.491478
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Annex A

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/07/433/001   | Nevanac   | 1 mg/ml   | Eye drops, suspension   | Ocular use   | Bottle (LDPE)       | 5 ml   | 1 bottle   |
|-------------------|-----------|-----------|-------------------------|--------------|---------------------|--------|------------|
| EU/1/07/433/002   | Nevanac   | 3 mg/ml   | Eye drops, suspension   | Ocular use   | Bottle (LDPE) round | 3 ml   | 1 bottle   |
| EU/1/07/433/003   | Nevanac   | 3 mg/ml   | Eye drops, suspension   | Ocular use   | Bottle (LDPE) oval  | 3 ml   | 1 bottle   |